France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis

France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis
France has become the first European country to give Abivax a green light to start clinical trials of ABX464 as a treatment for moderate-to-severe active ulcerative colitis. The therapy candidate is already being tested against HIV/AIDS. Belgium, Czech Republic, Germany, Hungary, Poland and Spain are expected to follow the French National Regulatory Authority in authorizing trials for ulcerative colitis. ABX464, which

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *